
Cassidy Bio is an AI-driven biotech company specializing in accelerating and optimizing gene editing therapeutic development. The company provides a bespoke predictive platform for guide RNA (gRNA) design, leveraging proprietary clinically relevant genomic data, advanced AI algorithms including large language models, and rigorous wet lab validation. Their platform enables rapid and comprehensive on/off-target predictions across multiple editing technologies and cell types, helping partners make faster, smarter, and safer decisions in gene editing therapy development. Cassidy Bio is led by experienced biotech and AI leaders and is based in Tel Aviv, Israel, positioning itself as a cutting-edge innovator in the gene editing therapeutics market.

Cassidy Bio is an AI-driven biotech company specializing in accelerating and optimizing gene editing therapeutic development. The company provides a bespoke predictive platform for guide RNA (gRNA) design, leveraging proprietary clinically relevant genomic data, advanced AI algorithms including large language models, and rigorous wet lab validation. Their platform enables rapid and comprehensive on/off-target predictions across multiple editing technologies and cell types, helping partners make faster, smarter, and safer decisions in gene editing therapy development. Cassidy Bio is led by experienced biotech and AI leaders and is based in Tel Aviv, Israel, positioning itself as a cutting-edge innovator in the gene editing therapeutics market.